Jobs / United States / Glaxosmithkline LLC
Medical Lead Oncology
Glaxosmithkline LLC · 🇺🇸 Baar Onyx
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles8 certified filings for “Principal Scientist” (Medical Scientists, Except Epidemiologists) in PA: $98k–$110k, median $98k. Most were filed at wage level I (63%) — 1 lottery entry, ≈15% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems. Our diverse portfolio consists of vaccines, specialty medicines, and general medicines. Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges. You will lead and shape Oncology medical activities in Switzerland. You will work closely with cross-functional colleagues across Medical Affairs, Clinical Operations, Market Access, Regulatory Affairs, and Commercial teams. You will build trusted relationships with healthcare professionals, societies and patient advocacy groups to bring clinical and patient insights back into strategy. We value clear scientific thinking, inclusive leadership, and a patient-first mindset. This role offers strong growth, visible impact on care, and alignment with GSK’s mission of uniting science, technology and talent to get ahead of disease together. In this role you will • Act as the scientific and clinical medical lead for Oncology in Switzerland with the main focus on gynaecological oncology, guiding local medical strategy and execution. • Lead, coach and develop a small Oncology medical team, including Medical Science Liaisons • Translate global and regional medical plans into country-level tactics and ensure compliant and timely delivery. • Build and maintain trusted relationships with healthcare professionals, academic centres and other external stakeholders. • Generate and communicate medical insights and evidence needs to inform regional and global strategy, clinical research and access activities. • Support clinical research initiatives including investigator-sponsored studies, collaborative projects and company-sponsored trials. Why You? Basic Qualifications & Skills We are looking for professionals with these required skills to achieve our goals: • Advanced degree in medicine, pharmacy, life sciences or related discipline (e.g. MD, PhD) or equivalent clinical/scientific experience. • Significant experience in medical affairs or clinical development within the pharmaceutical or healthcare sector, with relevant Oncology exposure. • Proven experience engaging in scientific exchange with external experts and clinical stakeholders. • Strong understanding of clinical data, evidence-based medicine and medical communications. • Excellent written and spoken English. Proficiency in local Swiss languages (German, French, or Italian) is an advantage. Preferred Qualifications & Skills Please note the following skills are not necessary, just preferred, if you do not have them, please still apply: • Clinical background in Oncology, such as a practising physician or equivalent clinical experience. • Experience managing people or leading small teams, including coaching and performance management. • Experience translating global or regional medical strategy into local country plans. • Experience in real-world evidence, investigator-sponsored research or clinical trial support. • Familiarity with the Swiss healthcare environment, reimbursement and access pathways. • Strong stakeholder management and cross-functional collaboration experience in a matrix organisation. • Experience presenting scientific content at congresses, advisory boards or educational events. Closing Date for Applications – 28th of September 2026 (C